Sleep Apnea Treatment

Research summary

• Obstructive sleep apnea (OSA) treatment is well supported by multiple clinical reviews describing CPAP as the primary evidence-based therapy, along with a systematic review and network meta-analysis of randomized trials finding myofunctional therapy improves sleepiness and sleep quality as an adjunct treatment, though without significant change in the apnea-hypopnea index itself.
• Reviews consistently describe OSA as a major modifiable contributor to cardiovascular disease, heart failure, and stroke risk, reinforcing why treatment matters.
• The evidence combines strong clinical consensus on CPAP efficacy with more recent controlled-trial evidence for adjunct therapies, giving a solid overall evidence base, while the comparative long-term effectiveness of newer alternative treatments is still an active area of research.